LongevidadXY // Male ProtocolPROTOCOL
NMN
CHEM_ID: Nicotinamide // BIO_AVAIL: Sublingual
XY Clinical Context: NAD+ decline, mitochondrial health, and cardiovascular risk reduction.
XY-Optimized
Clinical Protocol
VERIFIED BY: CHEMGRADE DATABASE // MALE PROTOCOL
Effective Dosage
500-1000mg
CLINICAL CONFIDENCE SCORE9/10
Administration Timing
Mañana (Sublingual)
XY Dosage Optimization
NAD+ supports mitochondrial efficiency in muscle tissue. Males show stronger performance response.
⚠️ Contraindications
Mantener frío.
View Other Profile
* Scientific Disclaimer: Consult a physician before supplementation. ChemGrade does not provide medical advice. Use of bioactive compounds is at your own risk.
Compound Profile
ProfileXY
Bio-AvailabilitySublingual
Half-Life2 Hours
Efficacy Score9/10
Clinical Context→
Read the mechanism of action.